Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology | Endocrinology | Family Medicine
 Disease Category: Pancreatic Cancer
Location: United States, WV

Trial Information

ACOSOG-Z5041: Ph2 of Neoadjuvant and Adjuvant Gemcitabine Hydrochloride and Erlotinib Hydrochloride in pts + Resectable Adenocarcinoma of the Pancreas Undergoing Pancreatectomy.

The purpose of this study is to find out whether Gemcitabine Hydrochloride and Erlotinib Hydrochloride given prior to surgery, can help to increase the success of removing the entire pancreatic tumor. This study is also designed to answer the question of whether the same combination of chemotherapy can be given safely after surgery and reduce the chances of the cancer returning after surgery.

West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South, PO Box 9260
Morgantown, WV 26506
Phone: 304-293-7374

View Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.